Integration update on BI’s acquisition of Merial
Boehringer Ingelheim’s (BI) acquisition of Sanofi’s animal health business – Merial – has closed. The acquisition makes BI the second largest animal health company in the world.
Steve Boren, VP of sales marketing for BI’s cattle business says the acquisition opens opportunity for research and development. He says they are making significant investments in preventative care.
AUDIO: Steve Boren, Boehringer Ingelheim
Dan Harter, executive director of US ruminant and equine business for Merial says the acquisition provides a great opportunity for livestock producers as more money will be invested in research and development.
AUDIO: Dan Harter, Merial
Your email address will not be published.
Subscribe for our newsletter today and receive relevant news straight to your inbox!